There are 3161 resources available
1818MO - Development and validation of a predictive model of aromatase inhibitor musculoskeletal toxicity (AIMT) among patients (pts) with early breast cancer (EBC)
Presenter: Pietro Lapidari
Session: Mini oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
LBA35 - Primary results from TACTI-003: A randomized phase IIb trial comparing eftilagimod alpha (soluble LAG-3) plus pembrolizumab versus pembrolizumab alone in first-line recurrent or metastatic head and neck squamous cell carcinoma with CPS ≥1
Presenter: Claus Kristensen
Session: Proffered paper session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
1209MO - Neoadjuvant nivolumab and nivolumab+ipilimumab in resectable non-small cell lung cancer: Combined analysis of 5-year outcomes from NEOSTAR and CA209-159
Presenter: Joshua Reuss
Session: Mini oral session 1: Non-metastatic NSCLC
Resources:
Abstract
Slides
Webcast
Epithelial ovarian cancer: Q&A
Session: ESMO Clinical Practice Guidelines 1
Resources:
Webcast
Invited Discussant LBA50 and 1209MO
Presenter: Céline Mascaux
Session: Mini oral session 1: Non-metastatic NSCLC
Resources:
Slides
Webcast
Invited Discussant 847O and LBA35
Presenter: Hisham Mehanna
Session: Proffered paper session: Head and neck cancer
Resources:
Slides
Webcast
Neoadjuvant immunotherapy in colon cancer: Are we there yet?
Presenter: Myriam Chalabi
Session: Neoadjuvant treatment for colon cancer: Building upon the existing data
Resources:
Slides
Webcast
Non-cellular therapies
Presenter: Olivier Michielin
Session: Systemic treatment of anti PD-1 resistance in advanced melanoma
Resources:
Slides
Webcast
Updates in penile cancer
Presenter: Andrea Necchi
Session: Focus on rare GU cancers: A common challenge
Resources:
Slides
Webcast
What is missing? The patient point of view
Presenter: Katie Rizvi
Session: Rare cancers
Resources:
Slides
Webcast